The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate

Neuropathology and Applied Neurobiology

Volumn 25, Issue 1, 1999, Pages 19-27

  Betmouni, S ^a,b   Perry, V H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

CNS; Inflammation; Microglia; Mouse; Prion; T cells

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN HOMOGENATE; CELL LOSS; CELL VACUOLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HIPPOCAMPUS; HISTOLOGY; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE;

EID: 0033036115     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00153.x     Document Type: Article

References (37)

1. 1 Andersson P-B, Perry VH, Gordon S. Intracerebral injection of proinflammatory cytokines or leucocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 1992; 176: 255-9
2. 2 Andersson P-B, Perry VH, Gordon S. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991; 42: 201-14
3. 3 Barcikowska M, Liberski PP, Boellaard JW, Brown P, Gajdusek DC, Budka H. Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Straussler-Scheinker syndrome. Acta Neuropathol 1993; 85: 623-7
4. 4 Bell JE, Gentleman SM, Ironside JW et al. Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 19: 1337-48
5. 5 Betmouni S, Perry VH, Gordon JL. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neurosrience 1996; 74: 1-5
6. 6 Bhattacharya A, Dorf ME, Springer TA, A. shared alloantigenic determinant of I-A and I-E subregions: evidence for I region gene duplication. J Immunol 1981; 127: 2488-95
7. 7 Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
8. 8 Brown DR, Schmidt B, Kretzschmar HA. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 1996; 18: 59-67
9. 9 Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996; 380: 345-7
10. 10 Cobbold SP, Jayasuriya A, Nas A, Prospero TD, Waldman H. Therapy with monoclonal antibodies by elimination of T-cell subsets In Vitro Nature 1984; 312: 548-51
11. 11 Collinge J, Owen F, Poulter M et al. Prion dementia without characteristic pathology. Lancet 1990; 336: 7-9
12. 12 Crocker PR. Novel cell surface adhesion receptor involved in interactions between stromal macrophages and haematopoietic cells. J Cell Sci (Suppl.) 1988; 9: 185-206
13. 13 DeArmond SJ, Mobley WC, DeMott BA, Barry RA, Beckstead JH, Prusiner MD. Changes in the localization of brain prion proteins during scrapie infection. Neurology 1987; 37: 1271-80
14. 14 Forloni G, Angeretti N, Chiesa R et al. Neurotoxicity of a prion protein fragment. Nature 1993; 362: 543-6
15. 15 Gotz ME, Kunig G, Reiderer P, Youdim MBH. Oxidative stress: Free radical production in neural degeneration. Pharmacol Therap 1994; 63: 37-122
16. 16 Guiroy DC, Wakayama I, Liberski PP, Gajdusek DC. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Staussler syndrome. Acta Neuropathol 1994; 87: 526-30
17. 17 Hope J, Shearman MS, Baxter HC, Chong A, Kelly SM, Price NC. Cytotoxicity of prion protein peptide (PrP 106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, Aß25-35. Neurodegeneration 1996; 5: 1-11
18. 18 Jeffrey M, Fraser H, Halliday WG, Fowler N, Goodsir CM, Brown DA. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol 1995; 21: 41-9
19. 19 Jeffrey M, Goodsir CM, Bruce ME, McBride PA, Fraser JR. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol Appl Neurobiol 1997; 23: 93-101
20. 20 Kretzschmar HA, Giese A, Brown DA, Herms J, Schmidt B, Groschup MH. Cell death in prion disease. In: Transmissible Subacute Spongiform Encephalopathies. Prion Disease. Court L and Dodet B, Eds. Elsevier, New York, 1996: 97-105
21. 21 Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in normal adult and mouse brain. Neuroscience 1990; 39; 151-70
22. 22 Maddox PH, Jenkins D. 3-aminopropyl-triethoxysilane (APES): a new advance in section adhesion. J Clin Pathol 1987; 40: 1256-7
23. 23 Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell IPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's Disease. Proc Natl Acad Sci USA 1985; 82: 4531-4
24. 24 Perovic S, Pergande G, Ushijima H, Kelve M, Forrest J, Mueller WEG. Flupiritine partially prevents neuronal injury induced by prion protein fragment and lead acetate. Neurodegeneration 1995; 4: 369-74
25. 25 Perry VH. Novel aspects of inflammation in the central nervous system. J Immunol Immunopharmacol 1995; 15: 92-5
26. 26 Perry VH, Bell MD, Brown HC, Matyszak MM. Inflammation in the nervous system. Curr Opin Neurobiol 1995; 5: 636-41
27. 27 Perry VH, Crocker PR, Gordon S. The blood brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J Cell Sci 1992; 101: 201-7
28. 28 Prusiner SB. Molecular biology and pathogenesis of prion diseases. TIBS 1996: 482-7
29. 29 Rabinowitz SS, Gordon S. Macrosialin, a macrophage restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 1991; 174: 827-36
30. 30 Schnell L, Schneider R, Berman MA, Perry VH, Schwab ME. Lymphocyte recruitment following spinal cord injury in mice is altered by prior viral exposure. Eur J Neurosci 1997; 9: 1000-7
31. 31 Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 1994; 55: 195-203
32. 32 Scott JR, Davies D, Fraser H. Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. J Gen Virol 1992; 73: 1637-44
33. 33 Springer TA. Cell surface differentiation in the mouse. Characterisation of 'Jumping' and 'Lineage' antigens using xenogeneic rat monoclonal antibodies. In. Monoclonal Antibodies and Hybridomas; a New Dimension in Biological Analysis. Kennett RH, Mckearn TJ and Bechtol KB, Eds. Plenum Press: New York, 1980: 185-217
34. 34 Tomonari K. A rat antibody against a structure functionally related to the mouse T-cell receptor/73 complex. Immunogenetics 1988; 28: 455-8
35. 35 Williams A, Lucassen PJ, Ritchie D, Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 1997; 144: 433-8
36. 36 Williams AE, Lawson LJ, Perry VH, Fraser H. Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 1994; 20: 47-55
37. 37 Williams AE, Ryder S, Blakemore WF. Monocyte recruitment into scrapie-affected brain. Acta Neuropathol 1995; 90: 164-9